314 related articles for article (PubMed ID: 22957668)
1. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
2. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
Andersson C; Larsson K; Vaziri-Sani F; Lynch K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Månsson M; Nilsson A; Lernmark A; Elding Larsson H; Ivarsson SA
Autoimmunity; 2011 Aug; 44(5):394-405. PubMed ID: 21244337
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
4. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
Wang JP; Zhou ZG; Lin J; Huang G; Zhang C; Yang L; Yuan Y; Zhou HF; Zhou M; Hou C; Zhou WD; Peng H; Hagopian WA
Tissue Antigens; 2007 Nov; 70(5):369-75. PubMed ID: 17919266
[TBL] [Abstract][Full Text] [Related]
5. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
Andersson C; Carlsson A; Cilio C; Cedervall E; Ivarsson SA; Jonsdottir B; Jönsson B; Larsson K; Neiderud J; Lernmark A; Elding Larsson H;
Pediatr Diabetes; 2013 Aug; 14(5):341-9. PubMed ID: 23469940
[TBL] [Abstract][Full Text] [Related]
6. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
[TBL] [Abstract][Full Text] [Related]
9. Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents.
Jonsdottir B; Andersson C; Carlsson A; Delli A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Ivarsson SA; Larsson HE;
Diabetologia; 2013 Aug; 56(8):1735-42. PubMed ID: 23666211
[TBL] [Abstract][Full Text] [Related]
10. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
[TBL] [Abstract][Full Text] [Related]
11. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
Vermeulen I; Weets I; Asanghanwa M; Ruige J; Van Gaal L; Mathieu C; Keymeulen B; Lampasona V; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
Diabetes Care; 2011 Aug; 34(8):1760-5. PubMed ID: 21715527
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
14. Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A*24 alleles at the onset of type 1 diabetes.
Long AE; Gillespie KM; Aitken RJ; Goode JC; Bingley PJ; Williams AJ
Diabetes; 2013 Jun; 62(6):2067-71. PubMed ID: 23396399
[TBL] [Abstract][Full Text] [Related]
15. Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.
Zhao LP; Alshiekh S; Zhao M; Carlsson A; Larsson HE; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Persson M; Samuelsson U; Örtqvist E; Pyo CW; Nelson WC; Geraghty DE; Lernmark Å;
Diabetes; 2016 Mar; 65(3):710-8. PubMed ID: 26740600
[TBL] [Abstract][Full Text] [Related]
16. Distribution of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross-sectional study.
Fan W; Nan X; Peng Y; Li X; Xiang Y; Yan X; Xie Z; Zhou H; Tang X; Cheng J; Niu X; Liu J; Ji Q; Ji L; Huang G; Zhou Z
Diabetes Metab Res Rev; 2023 Feb; 39(2):e3592. PubMed ID: 36401613
[TBL] [Abstract][Full Text] [Related]
17. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.
De Grijse J; Asanghanwa M; Nouthe B; Albrecher N; Goubert P; Vermeulen I; Van Der Meeren S; Decochez K; Weets I; Keymeulen B; Lampasona V; Wenzlau J; Hutton JC; Pipeleers D; Gorus FK;
Diabetologia; 2010 Mar; 53(3):517-24. PubMed ID: 20091020
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
19. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.
Delli AJ; Vaziri-Sani F; Lindblad B; Elding-Larsson H; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Örtqvist E; Groop L; Bondinas GP; Papadopoulos GK; Lernmark Å;
Diabetes; 2012 Oct; 61(10):2556-64. PubMed ID: 22787139
[TBL] [Abstract][Full Text] [Related]
20. Discordant association of islet autoantibodies with high-risk HLA genes in Chinese type 1 diabetes.
Gu Y; Zhang M; Chen H; Wang Z; Xing C; Yang H; Xu X; Liu Y; Zhou Z; Yu L; Hutton J; Eisenbarth G; Yang T
Diabetes Metab Res Rev; 2011 Nov; 27(8):899-905. PubMed ID: 22069282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
